Skip to content

Expert advice on optimal safety measures

Notary Affirms Documentation Concerning Inheritance, Power of Attorney, and Advance Care Directive on Thursday, 28th November, in Neuwied District

"Expert advice outlining optimal safety measures"
"Expert advice outlining optimal safety measures"

Expert advice on optimal safety measures

On Thursday, November 28, 2024, the Lower Agricultural Authority of Neuwied District Administration is hosting a seminar titled "What you can do today...". The event, which focuses on the topics of Will, Inheritance, Power of Attorney, and Advance Directive, will take place at the Out-of-School Learning Center in Linkenbach at 7:30 PM.

Noted speaker Notary Christopher Keim, Professor and Justice Councilor from Ingelheim, will lead the discussion. The seminar will be preceded by a welcoming speech from District Administrator Achim Hallerbach, who will introduce the topic.

Interested participants are invited to register for the event. Registration can be done via email at [email protected] or by phone at 02631/803-759. It is essential to note that registration should be completed by Tuesday, November 26, 2024, and that due to limited space, only the first 60 registrations will be considered.

For more information about the event or the Neuwied District Administration, please visit their official website at www.kreis-neuwied.de or contact Thomas Herschbach, the press spokesperson, at [email protected] or 02631/803-224.

The seminar is hosted by the Lower Agricultural Authority of Neuwied District Administration, located at Wilhelm-Leuschner-Str. 9, 56564 Neuwied. It is an excellent opportunity for individuals to gain valuable insights and knowledge on important legal matters.

  1. In preparation for the seminar on November 28, 2024, discussions are expected to cover various aspects of Economic and Social policy, including finance and business, alongside topics like Will, Inheritance, Power of Attorney, and Advance Directive.
  2. After the event, participants may find it beneficial to apply the knowledge gained to their personal or professional finances and businesses, utilizing the new insights to make informed decisions.

Read also:

    Latest

    Time for Debut Approaches for This Pharmaceutical Product

    Drug's Release is Imminent on Showtime

    Biopharmaceutical company Dynavax Technologies (NAS: DVAX) hints at a potential approval of Heplisav, as suggested by recent news. The firm revealed this week that the Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) has taken notice of the...